Xiao-Ling Guo Selected Research

Therapeutics

9/2018	Genome‑wide profiling of lncRNA expression patterns in patients with acute promyelocytic leukemia with differentiation therapy.
1/2014	Preparation of bufalin-loaded pluronic polyetherimide nanoparticles, cellular uptake, distribution, and effect on colorectal cancer.
8/2007	[Angioimmunoblastic T-cell lymphoma with autoimmune hemolytic anemia and pure red cell aplasia].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao-Ling Guo Research Topics

Disease

5	Neoplasms (Cancer) 03/2018 - 08/2005
3	Liver Cirrhosis (Hepatic Cirrhosis) 05/2015 - 01/2013
2	Fibrosis (Cirrhosis) 05/2015 - 01/2013
2	Asthma (Bronchial Asthma) 02/2015 - 12/2014
2	Lymphoma (Lymphomas) 08/2007 - 08/2005
1	Myocarditis (Carditis) 12/2021
1	Vitamin D Deficiency 08/2020
1	Premature Birth (Birth, Premature) 08/2020
1	Fetal Distress 08/2020
1	Gestational Diabetes (Gestational Diabetes Mellitus) 08/2020
1	Acute Promyelocytic Leukemia 09/2018
1	Brain Neoplasms (Brain Tumor) 03/2018
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 03/2018
1	Infections 01/2018
1	Patent Ductus Arteriosus 11/2015
1	Hypersensitivity (Allergy) 02/2015
1	Food Hypersensitivity (Food Allergy) 02/2015
1	Allergic Rhinitis 02/2015
1	Eczema 02/2015
1	Exfoliation Syndrome 01/2015
1	Colorectal Neoplasms (Colorectal Cancer) 01/2014
1	Neoplasm Metastasis (Metastasis) 01/2014
1	Colonic Neoplasms (Colon Cancer) 01/2014
1	Body Weight (Weight, Body) 06/2013
1	Liver Diseases (Liver Disease) 01/2013
1	Multiple Myeloma 10/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2008
1	Coinfection 01/2008
1	T-Cell Lymphoma (Lymphoma, T Cell) 08/2007
1	Sudden Infant Death (SID) 06/2007
1	Autoimmune Diseases (Autoimmune Disease) 08/2005
1	Type 2 Diabetes Mellitus (MODY) 11/2003
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2003
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2003

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2017 - 06/2007
1	PNU-282987IBA 12/2021
1	Vitamin D FDA LinkGeneric 08/2020
1	hydroxide ionIBA 08/2020
1	Long Noncoding RNAIBA 09/2018
1	Bevacizumab (Avastin)FDA Link 03/2018
1	Heavy MetalsIBA 01/2018
1	CadmiumIBA 01/2018
1	Poly I-CIBA 01/2018
1	Biological ProductsIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	pro-brain natriuretic peptide (1-76)IBA 11/2015
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 05/2015
1	Carbon Tetrachloride (Tetrachloromethane)IBA 05/2015
1	Eosine Yellowish-(YS) (Eosin)IBA 05/2015
1	Hematoxylin (Haematoxylon)IBA 05/2015
1	Penicillins (Penicillin)FDA Link 02/2015
1	Tobacco Smoke Pollution (Passive Smoking)IBA 02/2015
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2015
1	Interleukin-2 (IL2)IBA 12/2014
1	Immunoglobulin E (IgE)IBA 12/2014
1	interleukin-21 (interleukin 21)IBA 12/2014
1	CytokinesIBA 12/2014
1	Messenger RNA (mRNA)IBA 12/2014
1	Interleukin-6 (Interleukin 6)IBA 12/2014
1	bufalinIBA 01/2014
1	polyetherimideIBA 01/2014
1	Poloxamer (Poloxamer 407)IBA 01/2014
1	Olive OilIBA 06/2013
1	SolutionsIBA 06/2013
1	MicroRNAs (MicroRNA)IBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	Angiopoietin-1IBA 10/2010
1	TIE-2 Receptor (Receptor, TIE 2)IBA 10/2010
1	CurcuminIBA 02/2008
1	RNA (Ribonucleic Acid)IBA 01/2008
1	Peptides (Polypeptides)IBA 08/2005
1	HLA-A*02:01 antigenIBA 08/2005
1	DNA VaccinesIBA 08/2005
1	Immunoglobulins (Immunoglobulin)IBA 08/2005
1	Pharmaceutical PreparationsIBA 11/2003
1	Insulin ReceptorIBA 11/2003
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 11/2003
1	SurvivinIBA 06/2003

Therapy/Procedure

3	Therapeutics 09/2018 - 08/2007
2	Immunotherapy 08/2005 - 08/2005
1	Vagotomy 12/2021
1	Cesarean Section (Caesarean Section) 08/2020
1	Subcutaneous Injections 06/2013
1	Drug Therapy (Chemotherapy) 08/2007